Table 5.
Univariable and multivariable logistic regression analysis of selected variables as predictors of death in group of patients with abdominal pain (n = 97).
| Risk Parameters | Univariable | Multivariable | ||
|---|---|---|---|---|
| OR (±95% CI) | p-Value | OR (±95% CI) | p-Value | |
| Parameters at the Admission to the Hospital: | ||||
| Sex (for men) | 0.90 (0.23–3.48) | 0.878 | ||
| Age (for ≥65 years old) | 2.34 (0.60–9.05) | 0.213 | ||
| Pain in the chest | 4.72 (0.38–59.22) | 0.223 | ||
| Cough | 1 ref. | - | ||
| Standstill heard over the lung fields | 2.46 (0.43–13.97) | 0.300 | ||
| Stressed sounds heard over the lung fields | 0.96 (0.11–8.79) | 0.972 | ||
| Whistling sounds heard over the lung fields | 3.11 (0.28–34.14) | 0.346 | ||
| Diarrhea | 0.37 (0.04–3.20) | 0.362 | ||
| Vomiting | 0.95 (0.22–4.04) | 0.946 | ||
| Respiratory suport: | ||||
| Oxygen mustache cannula | 3.38 (0.56–20.01) | 0.175 | ||
| Face mask | 1 ref. | - | ||
| Venturi mask | 9.55 (0.53–172.35) | 0.121 | ||
| Passive oxygen therapy | 1 ref. | - | ||
| HFNC | 1 ref. | - | ||
| BiPAP/CPAP | 1 ref. | - | ||
| Respiratory therapy | 1 ref. | - | ||
| Laboratory parameters at admission: | ||||
| ASPAT (for: >40 U/L) | 1.83 (0.42–7.91) | 0.406 | ||
| ALAT (for: >40 U/L) | 2.14 (0.51–9.05) | 0.290 | ||
| Total bilirubin (for: >1.1 mg/dL) | 0.86 (0.09–8.01) | 0.890 | ||
| Amylase in blood (for: >160 U/L) | 1 ref. | - | ||
| Lipase (for >150 U/L) | 1 ref. | - | ||
| CRP (for: >5 mg/L) | 1 ref. | - | ||
| Procalcitonin (for: > 0.1 ng/mL) | 8.00 (1.41–45.21) | 0.016 | 8.00 (1.41–45.21) | 0.016 |
| Parameters during hospitalization: | ||||
| The most aggressive respiratory support during hospitalization: | ||||
| Whistling/rattling sounds | 1.76 (0.40–7.68) | 0.443 | ||
| HFNC | 1 ref. | - | ||
| BiPAP/CPAP | 1 ref. | - | ||
| Respirator therapy | 21.50 (1.69–272.56) | 0.016 | 0.085 (0.00–15.35) | 0.346 |
| Pneumonia | 5.78 (1.35–24.63) | 0.016 | 6.20 (0.92–41.74) | 0.057 |
| Hypovolemic shock | 10.62 (1.27–88.22) | 0.027 | 1.84 (0.02–138.23) | 0.779 |
| Cardiac shock | 1 ref. | - | ||
| Septic shock | 36.85 (3.27–415.19) | 0.003 | 1.31 (0.04–47.73) | 0.882 |
| Digastive tract hemorrhage:- upper part- lower part | 4.72 (0.37–59.22)1 ref. | 0.223- | ||
| Respiratory hemorrhage | 1 ref. | - | ||
| Transferred to the Intensive Care Unit | 18.21 (2.52–131.04) | 0.003 | 10.35 (0.13–848.87) | 0.292 |
| Laboratory parameters during hospitalization: | ||||
| ASPAT (for: >40 U/L) | 0.65 (0.11–3.60) | 0.620 | ||
| ALAT (for: >40 U/L) | 0.62 (0.11–3.33) | 0.574 | ||
| Total bilirubin (for: >1.1 mg/dL) | 2.26 (0.38–13.32) | 0.360 | ||
| Amylase in blood (for: >160 U/L) | 1 ref. | - | ||
| Lipase (for >150 U/L) | 1 ref. | - | ||
| CRP (for: >5 mg/L) | 1 ref. | - | ||
| Procalcitonin (for: > 0.1 ng/mL) | 16.62 (2.78–99.32) | 0.002 | 16.62 (2.78–99.32) | 0.002 |
HFNC, high flow nasal cannula; BiPAP/CPAP, bilevel positive airway pressure/continuous positive airway pressure; ASPAT, aspartate transaminase; ALAT, alanine aminotransferase; CRP, C-reactive protein; OR, odds ratio; ±95% CI, 95% confidence intervals.